Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C.

N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. Erratum in: N Engl J Med. 2009 May 28;360(22):2379.

2.

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.

Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R; Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Lancet Oncol. 2008 Sep;9(9):840-9. doi: 10.1016/S1470-2045(08)70204-3. Epub 2008 Aug 19.

PMID:
18718815
3.

Expression of heat shock proteins 60 and 70 is a marker of preservation-induced endothelial cell activation.

Eberl T, Amberger A, Hengster P, Steurer W, Widschwendtner M, Schröcksnadel H, Gnaiger E, Margreiter R.

Transplant Proc. 1999 Feb-Mar;31(1-2):1034-6. No abstract available.

PMID:
10083461
4.

[Increased uterine activity caused by biogenic amines].

Lechner W, Bergant A, Sölder E, Widschwendtner M, Kölle D.

Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:338. German. No abstract available.

PMID:
8118343

Supplemental Content

Loading ...
Support Center